Asset Management One
TEVA icon

Asset Management One’s Teva Pharmaceuticals TEVA Stock Holding History

Asset Management One’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9M Buy
439,943
+9,391
+2% +$313K 0.04% 375
2026
Q1 		$13M Sell
430,552
-14,890
-3% -$479K 0.04% 385
2025
Q4 		$14.1M Buy
445,442
+24,130
+6% +$594K 0.04% 378
2025
Q3 		$8.51M Sell
421,312
-10,928
-3% -$192K 0.02% 500
2025
Q2 		$7.24M Buy
432,240
+3,403
+0.8% +$54.9K 0.02% 530
2025
Q1 		$6.59M Sell
428,837
-28,534
-6% -$510K 0.02% 536
2024
Q4 		$10.4M Buy
457,371
+58,413
+15% +$1.06M 0.04% 426
2024
Q3 		$7.19M Sell
398,958
-2,321
-0.6% -$40.6K 0.03% 507
2024
Q2 		$6.52M Sell
401,279
-18,910
-5% -$291K 0.02% 508
2024
Q1 		$5.93M Sell
420,189
-32,482
-7% -$409K 0.02% 551
2023
Q4 		$4.74M Sell
452,671
-197,480
-30% -$1.84M 0.02% 604
2023
Q3 		$6.63M Buy
650,151
+34,395
+6% +$320K 0.03% 492
2023
Q2 		$4.64M Sell
615,756
-15,921
-3% -$129K 0.02% 612
2023
Q1 		$5.59M Buy
631,677
+10,266
+2% +$102K 0.03% 547
2022
Q4 		$5.8M Buy
621,411
+871
+0.1% +$7.6K 0.03% 518
2022
Q3 		$5.01M Buy
620,540
+69,326
+13% +$613K 0.03% 540
2022
Q2 		$4.14M Sell
551,214
-6,806
-1% -$59.3K 0.02% 636
2022
Q1 		$5.24M Sell
558,020
-20,477
-4% -$171K 0.02% 624
2021
Q4 		$4.87M Sell
578,497
-4,763
-0.8% -$43K 0.02% 678
2021
Q3 		$5.68M Sell
583,260
-12,554
-2% -$118K 0.02% 625
2021
Q2 		$5.9M Buy
595,814
+12,855
+2% +$136K 0.02% 622
2021
Q1 		$6.73M Sell
582,959
-25,590
-4% -$293K 0.03% 577
2020
Q4 		$5.81M Sell
608,549
-14,922
-2% -$143K 0.02% 603
2020
Q3 		$5.62M Buy
623,471
+81,547
+15% +$863K 0.03% 554
2020
Q2 		$6.68M Sell
541,924
-987
-0.2% -$11.2K 0.03% 484
2020
Q1 		$4.88M Buy
542,911
+855
+0.2% +$8.76K 0.03% 511
2019
Q4 		$5.31M Sell
542,056
-2,323
-0.4% -$20.7K 0.02% 607
2019
Q3 		$3.75M Sell
544,379
-1,476
-0.3% -$11.3K 0.02% 685
2019
Q2 		$5.04M Buy
545,855
+93,885
+21% +$1.13M 0.02% 612
2019
Q1 		$7.08M Sell
451,970
-1,091,311
-71% -$19.2M 0.04% 466
2018
Q4 		$23.8M Buy
1,543,281
+3,530
+0.2% +$72.4K 0.06% 351
2018
Q3 		$33.1M Buy
1,539,751
+63,537
+4% +$1.48M 0.07% 310
2018
Q2 		$35.9M Buy
1,476,214
+128,011
+9% +$2.61M 0.08% 275
2018
Q1 		$23M Buy
1,348,203
+45,036
+3% +$879K 0.05% 391
2017
Q4 		$24.7M Sell
1,303,167
-70,073
-5% -$1.05M 0.05% 369
2017
Q3 		$24.1M Sell
1,373,240
-28,350
-2% -$638K 0.06% 358
2017
Q2 		$46.5M Sell
1,401,590
-14,101
-1% -$436K 0.12% 195
2017
Q1 		$45.5M Sell
1,415,691
-120,084
-8% -$4.1M 0.12% 194
2016
Q4 		$55.7M Buy
1,535,775
+1,226,446
+396% +$49M 0.14% 163
2016
Q3 		$14.3M Sell
309,329
-15,453
-5% -$806K 0.21% 110
2016
Q2 		$16.3M Sell
324,782
-6,216
-2% -$331K 0.24% 97
2016
Q1 		$18M Sell
330,998
-34,141
-9% -$2M 0.26% 89
2015
Q4 		$24.2M Sell
365,139
-121,398
-25% -$7.5M 0.36% 57
2015
Q3 		$27.1M Buy
486,537
+21,357
+5% +$1.38M 0.41% 48
2015
Q2 		$27.6M Sell
465,180
-47,012
-9% -$2.9M 0.38% 45
2015
Q1 		$32M Buy
512,192
+62,747
+14% +$3.65M 0.39% 42
2014
Q4 		$25.7M Buy
449,445
+131,528
+41% +$7.33M 0.33% 53
2014
Q3 		$17M Buy
317,917
+239,857
+307% +$12.7M 0.24% 94
2014
Q2 		$4.12M Buy
78,060
+4,803
+7% +$245K 0.06% 349
2014
Q1 		$3.67M Buy
+73,257
New +$3.39M 0.06% 361

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Asset Management One's TEVA Position: Q2 2026 in Review

Asset Management One increased its Teva Pharmaceuticals (TEVA) stake by 2.2% in Q2 2026, buying an estimated $313K and bringing the position to 439,943 shares worth $14.9M. The position accounts for 0.04% of the portfolio, ranked #375.

Asset Management One first reported a position in TEVA in Q1 2014 and has held it in 50 quarters since. The position peaked at $55.7M in Q4 2016. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Asset Management One held 439,943 shares of Teva Pharmaceuticals worth $14.9M as of Q2 2026.
  • Asset Management One bought 9,391 Teva Pharmaceuticals shares in Q2 2026, an estimated $313K.
  • Teva Pharmaceuticals made up 0.04% of Asset Management One's portfolio in Q2 2026, its #375 holding.
  • Asset Management One first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 50 quarters since.
  • Asset Management One's Teva Pharmaceuticals position peaked at $55.7M in Q4 2016.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Asset Management One's 13F filing for Q2 2026, filed 28 Jul 2026.